Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1748-717X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors ; volume:9 ; number:1 ; day:24 ; month:4 ; year:2014 ; pages:1-10 ; date:12.2014
Radiation oncology ; 9, Heft 1 (24.4.2014), 1-10, 12.2014

Creator: Ciammella, Patrizia

Contributor: Podgornii, Ala
Galeandro, Maria
Micera, Renato
Ramundo, Dafne
Palmieri, Tamara
Cagni, Elisabetta
Iotti, Cinzia
SpringerLink (Online service)

DOI: 10.1186/1748-717X-9-97

URN: urn:nbn:de:1111-2016072619051

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ciammella, Patrizia
Podgornii, Ala
Galeandro, Maria
Micera, Renato
Ramundo, Dafne
Palmieri, Tamara
Cagni, Elisabetta
Iotti, Cinzia
SpringerLink (Online service)

Other Objects (12)

$Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases$

Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases

$Dosimetric impact of the positional imaging frequency for hypofractionated prostate radiotherapy – a voxel-by-voxel analysis$

Dosimetric impact of the positional imaging frequency for hypofractionated prostate radiotherapy – a voxel-by-voxel analysis

$Hypofractionated radiotherapy for prostate cancer$

Hypofractionated radiotherapy for prostate cancer

Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity

$Hypofractionated radiotherapy for localized prostate cancer$

Hypofractionated radiotherapy for localized prostate cancer

$Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis$

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

$Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity$

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity

$Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis$

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

$Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity$

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

$Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation$

Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation

$Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity$

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity

$SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment$

SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment

$Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases$

Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases

$Dosimetric impact of the positional imaging frequency for hypofractionated prostate radiotherapy – a voxel-by-voxel analysis$

Dosimetric impact of the positional imaging frequency for hypofractionated prostate radiotherapy – a voxel-by-voxel analysis

$Hypofractionated radiotherapy for prostate cancer$

Hypofractionated radiotherapy for prostate cancer

Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity

$Hypofractionated radiotherapy for localized prostate cancer$

Hypofractionated radiotherapy for localized prostate cancer

$Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis$

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

$Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity$

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity

$Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis$

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

$Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity$

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

$Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation$

Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation

$Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity$

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity

$SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment$

SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment

$Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases$

Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases

$Dosimetric impact of the positional imaging frequency for hypofractionated prostate radiotherapy – a voxel-by-voxel analysis$

Dosimetric impact of the positional imaging frequency for hypofractionated prostate radiotherapy – a voxel-by-voxel analysis

$Hypofractionated radiotherapy for prostate cancer$

Hypofractionated radiotherapy for prostate cancer

Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity

$Hypofractionated radiotherapy for localized prostate cancer$

Hypofractionated radiotherapy for localized prostate cancer

$Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis$

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

$Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity$

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity

$Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis$

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

$Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity$

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

$Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation$

Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation

$Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity$

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity

$SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment$

SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases

Dosimetric impact of the positional imaging frequency for hypofractionated prostate radiotherapy – a voxel-by-voxel analysis

Hypofractionated radiotherapy for prostate cancer

Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity

Hypofractionated radiotherapy for localized prostate cancer

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity

SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment

Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases

Dosimetric impact of the positional imaging frequency for hypofractionated prostate radiotherapy – a voxel-by-voxel analysis

Hypofractionated radiotherapy for prostate cancer

Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity

Hypofractionated radiotherapy for localized prostate cancer

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity

SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment

Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases

Dosimetric impact of the positional imaging frequency for hypofractionated prostate radiotherapy – a voxel-by-voxel analysis

Hypofractionated radiotherapy for prostate cancer

Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity

Hypofractionated radiotherapy for localized prostate cancer

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity

SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment

Related objects

Reset password